title: Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
abstract: The histogenesis of clear cell chondrosarcoma is still unclear: Apart from typical clear cell tumor areas, extensive production of woven bone formation suggests within the clear cell cartilagenous stroma is an intriguing phenomenon. Three cases of clear cell chondrosarcoma documented in the Bone Tumor Registry of Westphalia were examined for their patterns of osteonectin expression, and compared with other bone tumors of either osseous or cartilaginous origin, and with normal cartilage tissue. Found predominantly in osseous structures, the protein osteonectin takes part in the formation of new bone. The three clear cell chondrosarcomas showed a strong immunoexpression of osteonectin in clear cell, chondroid and in osseous tumor areas. Similarly, evidence of osteonectin was also found in osteoblastic and in chondroblastic osteosarcomas as well as in osteoblastomas. In contrast, osteonectin could not be demonstrated in the chondrosarcomas and mesenchymal chondrosarcomas from our registry that were analysed for comparison, and was found only minimally in the fibroblastic areas of dedifferentiated chondrosarcomas. The chondroblastic tumor components were always negative. There was no immunoexpression of osteonectin either in fetal or adult intervertebral disc tissue. The present immunohistochemical study of osteonectin has distinctly separated clear cell chondrosarcoma from the other variants of chondrosarcoma, and aptly verified the specificity of this entity. Moreover, the study would call for further histogenetic evaluation of clear cell chondrosarcoma, since the pattern of osteonectin expression in that tumor seems to indicate an osteogenic rather than a chondrogenic origin.
authors.affiliation: Gerhard-Domagk-Institut für Pathologie, Westfälische Wilhelms-Universität Münster, Federal Republic of Germany.
authors.forename: A
authors.initials: A
authors.lastname: Bosse
authors.forename: Y
authors.initials: Y
authors.lastname: Ueda
authors.forename: P
authors.initials: P
authors.lastname: Wuisman
authors.forename: D B
authors.initials: DB
authors.lastname: Jones
authors.forename: E
authors.initials: E
authors.lastname: Vollmer
authors.forename: A
authors.initials: A
authors.lastname: Roessner
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D000906:Antibodies / Q000378:metabolism; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology; D002146:Bony Callus / Q000033:anatomy & histology / Q000378:metabolism; D002356:Cartilage / Q000378:metabolism; D002417:Cattle; D002813:Chondrosarcoma / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D003593:Cytoplasm / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007403:Intervertebral Disc / Q000378:metabolism; D015676:Osteonectin / Q000378:metabolism*; D012516:Osteosarcoma / Q000378:metabolism / Q000473:pathology; D011817:Rabbits
chemical_list: D000906:Antibodies; D015676:Osteonectin